A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of initial single and
multiple subcutaneous injections of CNTO 1275 in the treatment of patients with moderate to
severe plaque psoriasis.